Compare Vir Biotechnology Inc. Common Stock (VIR) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B), while Vanguard Emerging Markets Stock Index Fund ETF trades at $58.7 (market cap $168.50B). The key difference: Vanguard Emerging Markets Stock Index Fund ETF is far larger — about 95.7× Vir Biotechnology Inc. Common Stock's market cap, and Vanguard Emerging Markets Stock Index Fund ETF is more actively traded (5,654,578 versus 2,764,948). Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Vanguard Emerging Markets Stock Index Fund ETF for 135 Days on average.
| VIR | VWO | |
|---|---|---|
Market Cap | $1.76B | $168.50B |
Volume | 2,764,948 | 5,654,578 |
Sector | Health | — |
52-Week High | $11.78 | $61.44 |
52-Week Low | $5.12 | $52.42 |
Typical Hold Time | 0 Days | 135 Days |
Enterprise Value | $1.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VWO trades at $59.68, down 0.08% on the day, with a neutral technical signal. The ETF's performance is influenced by mixed regional exposures, with strength in Taiwan's AI and semiconductor sectors but headwinds from China's economic slowdown. Recent news highlights institutional accumulation and comparisons with other international ETFs, emphasizing its emerging markets focus and 0.06% expense ratio.
The outlook for VWO hinges on emerging market dynamics, particularly tech growth in Taiwan versus China's recovery. Risks include concentrated regional exposure and currency fluctuations. Analyst sentiment is balanced, with technical indicators neutral but institutional interest growing, suggesting cautious optimism for long-term diversification benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
